FTSE 100 news / Companies and sectors / Haleon / 14 October 2026

Haleon (HLN): news on Wednesday 14 October 2026

+4.5 positive

Coverage of Haleon was mainly valuation commentary and a push behind its Excedrin brand. The tone leans mildly positive as both pieces raise the possibility that the shares are undervalued.

What drove it

valuation debate
Excedrin push

The 2 stories

Each headline's own score, strongest first. Links go to the publisher.

+5.7 Haleon (LSE:HLN) Unveils Excedrin Push, Is The Valuation Gap An Opportunity? Yahoo Finance
Excedrin product push and valuation gap framed as opportunity.
+3.0 Is Haleon (LSE:HLN) Undervalued After A 11% Three Year Return? Yahoo Finance
Valuation commentary on Haleon suggesting possible undervaluation, modest three-year return.

Haleon: every day · Pharma and healthcare on 14 October 2026 · FTSE 100 overview for the day